With new Alzheimer's prevention trial, Roche and Genentech may put amyloid hypothesis to ultimate test
If the dozens of trials over the last two decades haven’t yielded a conclusive result, Roche and Genentech may soon finally put the amyloid hypothesis …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
